
DataHarmony is a pre-seed startup founded in December 2023 that provides a secure, browser-based platform to streamline gene editing and gene therapy R&D. Their platform offers experiment design, tracking, analysis, and reporting with intelligent guidance and automation to reduce risks and accelerate innovation in healthcare research. It supports a wide range of gene editing applications including disease modeling, cell line engineering, and pre-clinical gene therapy R&D. The company integrates third-party sequencing and molecular cloning software to enhance research efficiency and quality, aiming to improve the reliability and speed of gene editing experiments for basic, applied, and clinical research.

DataHarmony is a pre-seed startup founded in December 2023 that provides a secure, browser-based platform to streamline gene editing and gene therapy R&D. Their platform offers experiment design, tracking, analysis, and reporting with intelligent guidance and automation to reduce risks and accelerate innovation in healthcare research. It supports a wide range of gene editing applications including disease modeling, cell line engineering, and pre-clinical gene therapy R&D. The company integrates third-party sequencing and molecular cloning software to enhance research efficiency and quality, aiming to improve the reliability and speed of gene editing experiments for basic, applied, and clinical research.